Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dieci, M V"'
Autor:
Zanelli, S, Fiorio, E, Zampiva, I, Zacchi, F, Borghesani, G, Giontella, E, Parolin, V, Biondani, P, Zuliani, S, Dieci, M V, Mioranza, E, Zorzi, M, Conti, M, Gibellini, D, Verlato, G, Milella, M
Publikováno v:
Annals of Oncology
Publikováno v:
ESMO open. 7(2)
Studies testing the addition of lapatinib to neoadjuvant trastuzumab + chemotherapy reported an increase in pathologic complete response (pCR), with, nevertheless, discordant results in terms of survival, mainly due to suboptimal power. We here lever
Publikováno v:
Cells
Cells, Vol 10, Iss 223, p 223 (2021)
Cells, Vol 10, Iss 223, p 223 (2021)
In recent decades, the increasing interest in the field of immunotherapy has fostered an intense investigation of the breast cancer (BC) immune microenvironment. In this context, tumor-infiltrating lymphocytes (TILs) have emerged as a clinically rele
Publikováno v:
Cancer treatment reviews. 88
The overexpression of human epidermal growth factor receptor-2 (HER2) results in a biologically and clinically aggressive breast cancer (BC) subtype. Since the introduction of anti-HER2 targeted agents, survival rates of patients with HER2-positive m
Autor:
Maria Vittoria Dieci, Aicha Goubar, Giancarlo Bisagni, Gaia Griguolo, Daniele Generali, Valentina Guarneri, A. Michelotti, Antonio Frassoldati, Rossana Berardi, Fabio Puglisi, Guido Ficarra, Katia Cagossi, Federico Piacentini, Giuseppe Luigi Banna, Pierfranco Conte, Luigi Cavanna
Publikováno v:
Breast Cancer Research and Treatment. 163:295-302
PURPOSE: The aim was to evaluate the role of tumor-infiltrating lymphocytes (TIL) in predicting molecular response after preoperative endocrine or cytotoxic treatment for HR+/HER2- patients who do not achieve a pathological complete response. METHODS
Autor:
Nadia Naldi, Katia Cagossi, Federico Piacentini, Daniela Boggiani, Antonino Musolino, Daniele Zanoni, Luca Gianni, Daniele Generali, Anita Rimanti, Pierfranco Conte, P. Sgargi, Maria Vittoria Dieci, Valentina Guarneri, Massimo Ambroggi, Samanta Sarti, Giancarlo Bisagni, Andrea Ardizzoni
Publikováno v:
The pharmacogenomics journal. 16(5)
Lapatinib enhances antibody-dependent cell-mediated cytotoxicity (ADCC) activity of trastuzumab. FcγR polymorphisms have been associated with both ADCC and clinical activity of trastuzumab in HER2+ breast cancer (BC) patients (pts). We analyzed Fcγ